1. Cancer immunotherapy update: FDA-approved checkpoint inhibitors and companion diagnostics [Internet];Twomey;AAPS J,2021
2. European Medicines Agency: Committee for Medicinal Products for Human Use (CHMP) Assessment Report: Opdualag [Internet]. 2022 [cited 2023 May 19] Available from: https://www.ema.europa.eu/en/documents/assessment-report/opdualag-epar-public-assessment-report_en.pdf.
3. Five-year survival with combined nivolumab and ipilimumab in advanced melanoma;Larkin;N Engl J Med,2019
4. European Medicines Agency EMA: Yervoy Summary of Product Characteristics [Internet][cited 2023 May 22] Available from: https://www.ema.europa.eu/en/documents/product-information/yervoy-epar-product-information_en.pdf.
5. Group D.O.M.: Unresectable Melanoma Clinical Practice Guidelines [Internet], 2020[cited 2023 May 19] Available from: https://www.melanoma.dk/assets/files/Melanoma_Guidelines_Onkologisk_behandling_af_inoperabel_metastatisk_melanom.pdf.